News
-
AusPARS additions
Wednesday | Feb 19 2014Astellas’ Betmiga (mirabegron) for overactive bladder syndrome, Pfizer’s Prevenar 13 (13-valent pneumococcal conjugate vaccine) and Bayer’s.
-
Botulin toxin adverts
Wednesday | Feb 19 2014Four botulin cosmetic companies in the UK have been censured for alleged advertising of prescription only.
-
Corum profit dives
Wednesday | Feb 19 2014Listed pharmacy software provider Corum Group this morning reported a 36.7% reduction in its half year.
-
PD breaking news – Patrick Davies to become ceo of EBOS Group
Wednesday | Feb 19 2014Symbion chief to take on expanded role with parent company.
-
New e-script incentives
Tuesday | Feb 18 2014Among the Agreement programs announcements last week was confirmation of a new incentive payment to eligible.
-
‘Don’t be a fool’ campaign
Tuesday | Feb 18 2014Community pharmacies are being encouraged to play a key role in community-based bowel cancer screening programs.
-
TGA EU consultations
Tuesday | Feb 18 2014The Therapeutic Goods Administration has launched a series of consultations on whether Australia should adopt several.
-
Vimizim US approval
Tuesday | Feb 18 2014The US Food and Drug Administration has approved Vimizim (elosulfase alfa) which is the first FDA-approved.
-
Antidepressant switch
Tuesday | Feb 18 2014This week’s edition of the RGH Pharmacy E-Bulletin gives an overview of recommendations for patients changing.